155 related articles for article (PubMed ID: 9078465)
1. Expression and processing of the human immunodeficiency virus type 1 envelope glycoprotein.
Chen SS
Intervirology; 1996; 39(4):242-8. PubMed ID: 9078465
[TBL] [Abstract][Full Text] [Related]
2. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
[TBL] [Abstract][Full Text] [Related]
3. Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.
Merat R; Raoul H; Leste-Lasserre T; Sonigo P; Pancino G
J Virol; 1999 Jul; 73(7):5698-706. PubMed ID: 10364320
[TBL] [Abstract][Full Text] [Related]
4. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.
Binley JM; Sanders RW; Master A; Cayanan CS; Wiley CL; Schiffner L; Travis B; Kuhmann S; Burton DR; Hu SL; Olson WC; Moore JP
J Virol; 2002 Mar; 76(6):2606-16. PubMed ID: 11861826
[TBL] [Abstract][Full Text] [Related]
6. The extracellular processing of HIV-1 envelope glycoprotein gp160 by human plasmin.
Okumura Y; Yano M; Murakami M; Mori S; Towatari T; Kido H
FEBS Lett; 1999 Jan; 442(1):39-42. PubMed ID: 9923600
[TBL] [Abstract][Full Text] [Related]
7. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
Rodriguez D; Rodriguez JR; Esteban M
AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
[TBL] [Abstract][Full Text] [Related]
8. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
Fenouillet E; Jones IM
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
[TBL] [Abstract][Full Text] [Related]
9. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
Fenouillet E; Miquelis R; Drillien R
Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
[TBL] [Abstract][Full Text] [Related]
10. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
Ashorn P; Berger EA; Moss B
Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369
[No Abstract] [Full Text] [Related]
12. Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses.
Blay WM; Kasprzyk T; Misher L; Richardson BA; Haigwood NL
J Virol; 2007 Dec; 81(23):13037-49. PubMed ID: 17855534
[TBL] [Abstract][Full Text] [Related]
13. Natural variation in the amino acid sequence around the HIV type 1 glycoprotein 160 cleavage site and its effect on cleavability, subunit association, and membrane fusion.
Adams O; Schaal H; Scheid A
AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1235-45. PubMed ID: 10957721
[TBL] [Abstract][Full Text] [Related]
14. Role of HIV-1 envelope V3 loop cleavage in cell tropism.
Gu R; Westervelt P; Ratner L
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475
[TBL] [Abstract][Full Text] [Related]
15. Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
Witt KC; Castillo-Menendez L; Ding H; Espy N; Zhang S; Kappes JC; Sodroski J
PLoS One; 2017; 12(2):e0170672. PubMed ID: 28151945
[TBL] [Abstract][Full Text] [Related]
16. Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage.
Fenouillet E; Gluckman JC
Virology; 1992 Apr; 187(2):825-8. PubMed ID: 1372142
[TBL] [Abstract][Full Text] [Related]
17. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein.
Weiss CD; White JM
J Virol; 1993 Dec; 67(12):7060-6. PubMed ID: 8230430
[TBL] [Abstract][Full Text] [Related]
18. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity.
Mathys L; François KO; Quandte M; Braakman I; Balzarini J
PLoS One; 2014; 9(6):e101181. PubMed ID: 24967714
[TBL] [Abstract][Full Text] [Related]
20. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.
Moulard M; Achstetter T; Kieny MP; Montagnier L; Bahraoui E
Eur J Biochem; 1994 Oct; 225(2):565-72. PubMed ID: 7957171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
